BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15579066)

  • 1. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
    Andréola ML
    Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
    de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
    J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT.
    Métifiot M; Leon O; Tarrago-Litvak L; Litvak S; Andréola ML
    Biochimie; 2005; 87(9-10):911-9. PubMed ID: 16164998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H.
    Corona A; di Leva FS; Rigogliuso G; Pescatori L; Madia VN; Subra F; Delelis O; Esposito F; Cadeddu M; Costi R; Cosconati S; Novellino E; di Santo R; Tramontano E
    Antiviral Res; 2016 Oct; 134():236-243. PubMed ID: 27659398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
    Marchand C; Beutler JA; Wamiru A; Budihas S; Möllmann U; Heinisch L; Mellors JW; Le Grice SF; Pommier Y
    Antimicrob Agents Chemother; 2008 Jan; 52(1):361-4. PubMed ID: 17967911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.
    Costi R; Métifiot M; Esposito F; Cuzzucoli Crucitti G; Pescatori L; Messore A; Scipione L; Tortorella S; Zinzula L; Novellino E; Pommier Y; Tramontano E; Marchand C; Di Santo R
    J Med Chem; 2013 Nov; 56(21):8588-98. PubMed ID: 24124919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
    Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.
    Esposito F; Tramontano E
    Antivir Chem Chemother; 2014 Jan; 23(4):129-44. PubMed ID: 24150519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase.
    Pescatori L; Métifiot M; Chung S; Masoaka T; Cuzzucoli Crucitti G; Messore A; Pupo G; Madia VN; Saccoliti F; Scipione L; Tortorella S; Di Leva FS; Cosconati S; Marinelli L; Novellino E; Le Grice SF; Pommier Y; Marchand C; Costi R; Di Santo R
    J Med Chem; 2015 Jun; 58(11):4610-23. PubMed ID: 25961960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
    Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
    Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges.
    Kharkwal H; Kumar BK; Murugesan S; Singhvi G; Avasthi P; Goyal A; Jamalis J; Chander S
    Future Med Chem; 2021 Feb; 13(3):269-286. PubMed ID: 33399497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors.
    Carcelli M; Rogolino D; Sechi M; Rispoli G; Fisicaro E; Compari C; Grandi N; Corona A; Tramontano E; Pannecouque C; Naesens L
    Eur J Med Chem; 2014 Aug; 83():594-600. PubMed ID: 24996145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
    Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
    Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
    Wu B; Tang J; Wilson DJ; Huber AD; Casey MC; Ji J; Kankanala J; Xie J; Sarafianos SG; Wang Z
    J Med Chem; 2016 Jul; 59(13):6136-48. PubMed ID: 27283261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold.
    Williams PD; Staas DD; Venkatraman S; Loughran HM; Ruzek RD; Booth TM; Lyle TA; Wai JS; Vacca JP; Feuston BP; Ecto LT; Flynn JA; DiStefano DJ; Hazuda DJ; Bahnck CM; Himmelberger AL; Dornadula G; Hrin RC; Stillmock KA; Witmer MV; Miller MD; Grobler JA
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6754-7. PubMed ID: 20869872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
    Yang F; Zheng G; Fu T; Li X; Tu G; Li YH; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2018 Sep; 20(37):23873-23884. PubMed ID: 29947629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.